Status:
TERMINATED
Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Lead Sponsor:
Centre Jean Perrin
Collaborating Sponsors:
Fondation de l'Avenir et la MASFIP, Paris - France
Conditions:
Hereditary Breast and Ovarian Cancer Syndrome
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Young female counselees (18-40 years) belonging to HBOC families with a known mutation on BRCA-genes or not, receive a lot of information regarding their cancer risk. Information sources are numerous ...
Detailed Description
Background: Young women exposed to a high hereditary breast/ovaries cancer (HBOC) risk are particularly vulnerable: they are ignored by health prevention measures; they are embedded in a stream of con...
Eligibility Criteria
Inclusion
- Participants must belong to HBOC families,
- aged between 18 and 40 years
- Single or couple with a desire to have a child
- without any personal history of cancer.
- must have consulted at the oncogenetics department of the CCC Jean Perrin
- tested for a BRCA mutation.
- mutation carrier in case of a known familial BRCA mutation, else exposed to a high familial HBOC risk (Eisinger score ≥ 6 or Manchester score ≥ 16)
- must live in Auvergne region (middle France)
- signed an informed consent before inclusion.
Exclusion
- pregnant women
- person who cannot answer questionnaires: language difficulties and/or cannot write in French correctly.
- no possible connection to our web-site
- psychiatric troubles and/or ongoing treatments preventing from a week-end stay in a SPA resort
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT02705924
Start Date
April 1 2016
End Date
September 14 2021
Last Update
November 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Jean Perrin
Clermont-Ferrand, Puy De Dome, France, 63011